Search results for: 'research area pi3k akt signaling pi3k inhibitors'
-
A8633 Concanamycin A1 CitationTarget: Vacuolar-type ATPaseSummary: V-type (vacuolar) H+-ATPase inhibitor
-
B2266 LDE225 (NVP-LDE225,Erismodegib)1 CitationTarget: SmoothenedSummary: Smoothened inhibitor,potent and selective
-
A2133 Saracatinib (AZD0530)3 CitationTarget: SrcSummary: Src/Abl inhibitor,potent and selective
-
A4096 Belinostat (PXD101)2 CitationTarget: Histone Deacetylases (HDACs)Summary: Hydroxamate-type HDAC inhibitor
-
A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive
-
B4890 HPOB1 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6 inhibitor, potent and selective
-
A8219 Gefitinib (ZD1839)3 CitationTarget: EGFRSummary: Selective EGFR inhibitor
-
B4900 Indoximod (NLG-8189)Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor
-
A5343 Ispinesib (SB-715992)Target: KspSummary: Kinesin spindle protein (KSP)inhibitor
-
A1882 Cediranib (AZD217)Target: VEGFRSummary: VEGFR inhibitor receptor,highly potent